DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $816,102 | -49.8% | 64,159 | -44.4% | 0.00% | -60.0% |
| Q2 2023 | $1,625,888 | -31.9% | 115,475 | -25.3% | 0.01% | -50.0% |
| Q1 2023 | $2,388,647 | +100.3% | 154,605 | +112.5% | 0.01% | +100.0% |
| Q4 2022 | $1,192,307 | +4.6% | 72,746 | +18.0% | 0.01% | -16.7% |
| Q3 2022 | $1,140,000 | +566.7% | 61,630 | +235.1% | 0.01% | +500.0% |
| Q1 2022 | $171,000 | -77.8% | 18,394 | -76.7% | 0.00% | -50.0% |
| Q4 2021 | $771,000 | +69.5% | 78,932 | +489.5% | 0.00% | +100.0% |
| Q3 2021 | $455,000 | -25.8% | 13,390 | -20.0% | 0.00% | -50.0% |
| Q2 2021 | $613,000 | -21.9% | 16,738 | -4.4% | 0.00% | -60.0% |
| Q1 2021 | $785,000 | +5.4% | 17,511 | +34.2% | 0.01% | -16.7% |
| Q4 2020 | $745,000 | +58.2% | 13,053 | +42.3% | 0.01% | 0.0% |
| Q3 2020 | $471,000 | -57.7% | 9,174 | -80.9% | 0.01% | -50.0% |
| Q1 2019 | $1,113,000 | +34.9% | 47,971 | +22.0% | 0.01% | +20.0% |
| Q4 2018 | $825,000 | -36.0% | 39,306 | +18.1% | 0.01% | -33.3% |
| Q3 2018 | $1,289,000 | +16.8% | 33,278 | +18.6% | 0.02% | 0.0% |
| Q2 2018 | $1,104,000 | – | 28,057 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |